Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. - Test2 - elhamkhani - TriplyDB

Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation.

Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation.

http://www.wikidata.org/entity/Q33811085

about

A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease Disruptions of Host Immunity and Inflammation by Giardia Duodenalis: Potential Consequences for Co-Infections in the Gastro-Intestinal Tract A refined palate: bacterial consumption of host glycans in the gut Intestinal barrier in inflammatory bowel disease Immunopathology of inflammatory bowel disease Role of Cytokine-Induced Glycosylation Changes in Regulating Cell Interactions and Cell Signaling in Inflammatory Diseases and Cancer Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut Helminthic therapy: improving mucosal barrier function Introduction to the human gut microbiota Discordance between changes in the gut microbiota and pathogenicity in a mouse model of spontaneous colitis.Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution.iNOS-dependent increase in colonic mucus thickness in DSS-colitic rats.The composition of the gut microbiota throughout life, with an emphasis on early life.Lectin staining shows no evidence of involvement of glycocalyx/mucous layer carbohydrate structures in development of celiac disease Metronidazole or Cotrimoxazole therapy is associated with a decrease in intestinal bioavailability of common antiretroviral drugs.An integrative view of microbiome-host interactions in inflammatory bowel diseases The Goblet Cell Protein Clca1 (Alias mClca3 or Gob-5) Is Not Required for Intestinal Mucus Synthesis, Structure and Barrier Function in Naive or DSS-Challenged Mice.A Preliminary Study Examining the Binding Capacity of Akkermansia muciniphila and Desulfovibrio spp., to Colonic Mucin in Health and Ulcerative Colitis.Normalization of Host Intestinal Mucus Layers Requires Long-Term Microbial Colonization Symbiotic Human Gut Bacteria with Variable Metabolic Priorities for Host Mucosal Glycans.Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis.Discovery of intramolecular trans-sialidases in human gut microbiota suggests novel mechanisms of mucosal adaptation Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice Cranberry proanthocyanidins improve the gut mucous layer morphology and function in mice receiving elemental enteral nutrition.Detailed O-glycomics of the Muc2 mucin from colon of wild-type, core 1- and core 3-transferase-deficient mice highlights differences compared with human MUC2.Structural Characterization of Mucin O-Glycosylation May Provide Important Information to Help Prevent Colorectal Tumor Recurrence A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility.Host-microbiota interactions in inflammatory bowel disease.Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.Microbiotas from UC patients display altered metabolism and reduced ability of LAB to colonize mucus The mucin Muc2 limits pathogen burdens and epithelial barrier dysfunction during Salmonella enterica serovar Typhimurium colitis.Mucin-type O-glycans and their roles in intestinal homeostasis.Core 1- and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in mice Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease.Genome reference and sequence variation in the large repetitive central exon of human MUC5AC.The challenge and promise of glycomics.Eukaryotic protein glycosylation: a primer for histochemists and cell biologists Cell surface protein glycosylation in cancer.The role of glycosylation in IBD.

P2860

Q26751472-6DC85D6D-8B80-4581-AE8E-E459DF49662E Q26771122-BBA30B4D-FA6A-4047-AE7A-B3C80A632171 Q26825638-18B1455E-3D34-40DD-86E9-56D5BAFF37A3 Q27001407-549FD45D-BBCF-4A77-8259-872D70963C0F Q27023724-50094696-D1BC-4CB3-BCB4-6B9916652FA3 Q27027636-D9281B45-560B-46D1-8EA9-FCD6C8B606DD Q28077907-D5A501FB-61E7-4CFE-A566-54A932F1FDC9 Q28081848-6EFDB86F-F1CC-42B2-94E0-0FAA59B79A75 Q28263272-224E269E-0D11-48C0-A968-476CDDA012E9 Q33693158-69E91209-A9D6-4742-9035-43951B89F89A Q34129323-0727DC87-1EAE-4F0E-8EDC-073115EF82BE Q34801672-59C0C7A0-2AA2-4C14-9D3C-9380CA32683A Q34972470-294A7B97-6836-4535-9558-E3EC65B5901D Q35044607-55543D4A-69AF-46B3-A8EA-1CB4B85D3730 Q35047105-6ABB72FC-C9AE-4BD0-BC09-5BDBA93FC3ED Q35108410-DF00D9FA-700D-440E-872C-4E824BDA9B1B Q35631737-D86243CA-CF6C-4E0F-B0F5-D0276FE4C12E Q35688253-74E46067-153F-4A62-896F-B4169EA93024 Q35817095-83A620EF-DD09-4F4C-9AC6-CD17D001D8B3 Q35829763-70C52C9C-93F3-4A87-BA80-64E092D34CFF Q35837797-C1E123C8-A4AA-455A-BA73-0C430A200485 Q35867610-F110162A-7367-4703-9D18-CC6E968529FE Q35877592-410C03B1-7C1F-4507-8ADD-C635E5F7D80D Q35983991-EFF6DC54-B31D-4719-89D5-3D08CD28ABD1 Q36044764-46240F77-E985-4343-AACF-FAF9B46BAB26 Q36056064-F890167F-7283-4458-9239-7383F12A2589 Q36133931-AA6E7052-1F65-47F0-8214-5B433DFDA64D Q36198073-A7B37DE7-EC85-4E35-99D0-80F93B0F3FA6 Q36295242-979C0652-89AB-455A-8E45-98E9500ACB53 Q36328299-2F06240E-A1C7-43BA-886B-115649215097 Q36554337-E66968B1-66A2-4A77-8124-1E056E509A90 Q37264731-8B7956B1-50D6-427F-964B-6F4A70377B82 Q37380400-C65579B5-A7BC-4C07-8770-E44B4536B78E Q37395969-2CE9A355-83C3-4BB4-B13E-ACAE332B2BBD Q37570542-35A66953-3F50-4449-A3AB-D742E8335679 Q37596109-A6EECC25-89D8-4759-BE11-880EDCDE1C60 Q37638949-4099EAA0-C42B-4B4E-83E3-24D9FFC79942 Q37639440-F933FCF8-DA87-4962-B75D-CCDD14185FC1 Q38171440-EED6B159-6E02-4BBA-9F96-50C9F9E8CD74 Q38218832-E2F588AE-20B9-4046-9FCF-1018D43B6379

P2860

Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation.

http://www.wikidata.org/entity/Q33811085

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Altered O-glycosylation profil ...... d with increased inflammation.

@ast

Altered O-glycosylation profil ...... d with increased inflammation.

@en

type

label

Altered O-glycosylation profil ...... d with increased inflammation.

@ast

Altered O-glycosylation profil ...... d with increased inflammation.

@en

prefLabel

Altered O-glycosylation profil ...... d with increased inflammation.

@ast

Altered O-glycosylation profil ...... d with increased inflammation.

@en

P1433

Q33811085-DA3DF617-B6CC-4CD6-8CDE-EF750EA2AFB0

P1476

Q33811085-5B27C1C8-F88D-41CE-A058-D150CDCC0663

P2093

Q33811085-72DCC6A8-63FD-4841-8B0D-CA11C390737A

Q33811085-9397902D-9A49-4168-B743-5F2D1090D256

Q33811085-A284703B-B31B-4BC7-80CD-28003B3F4CFB

Q33811085-B47338B8-428B-4DB3-A7C4-5D1B7D2EBED1

Q33811085-F22C36FE-A0B4-4D04-9BA5-23C10F0967B1

P304

Q33811085-FCD0BB04-F924-4F66-A354-4EFC24E786C0

P31

Q33811085-6972D276-63D7-4C49-85E0-B11527AA83FA

P356

Q33811085-3A55C67A-80C6-4F76-AA59-A072083F0AC2

P433

Q33811085-EB630D9C-70CB-4E76-A8C5-C35253E82F8C

P478

Q33811085-AC5A1CB7-A916-421B-9E2F-E9FCCD685C3D

P50

Q33811085-93270885-CE76-4411-8413-F61CA312202A

Q33811085-C5A3BDC5-D665-4AED-A73D-B203EA795FDF

P577

Q33811085-957325C7-F417-4A4F-9A6B-7FACE827AA78

P5875

Q33811085-CEE5A330-62F0-410D-AF78-C0ED2641C624

P698

Q33811085-2256372A-B3F4-4071-AD50-26D1CA4679E9

P921

Q33811085-E610FC89-A34C-4ABF-88E3-385EFB63DFDC

P356

P1433

Inflammatory Bowel Diseases

P1476

Altered O-glycosylation profil ...... ed with increased inflammation

@en

P2093

Hasse Karlsson

http://www.w3.org/2001/XMLSchema#string

Henrik Sjövall

http://www.w3.org/2001/XMLSchema#string

Jessica Gråberg Crespo

http://www.w3.org/2001/XMLSchema#string

Jessica M Holmn Larsson

http://www.w3.org/2001/XMLSchema#string

Lisbeth Eklund

http://www.w3.org/2001/XMLSchema#string

P304

2299-2307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IBD.21625

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Gunnar C Hansson

Malin E. V. Johansson

P577

2011-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49807059

http://www.w3.org/2001/XMLSchema#string

P698

21290483

http://www.w3.org/2001/XMLSchema#string

P921